Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Modified nanofibers improve finasteride skin absorption.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Finasteride doesn't affect hormone levels in normal men.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Elagolix did not effectively treat polycystic ovary syndrome.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Clascoterone may be a promising treatment for hair loss.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

Hormonal therapies effectively treat acne and improve quality of life.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

The research helps understand how finasteride works and aids drug development.

The inhibitor affects androgen metabolism but not ovarian function.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.